Abstract
With hundreds of SARS-CoV-2 lineages circulating in the global population, there is an urgent need for forecasting lineage frequencies and thus identifying rapidly expanding lineages. To address this need, we constructed a framework for SARS-CoV-2 lineage frequency forecasting (CovTransformer), based on the transformer architecture. We designed our framework to navigate challenges such as a limited amount of data with high levels of noise and bias. We first trained and tested the model using data from the UK and the US, and then tested the generalization ability of the model on data collected across the globe. Remarkably, the model makes predictions two months into the future with high levels of accuracy in 31 countries. Finally, we show that our model performed substantially better than the current gold-standard, i.e. a regression-based model implemented in Nextstrain. Overall, our work demonstrates transformer models represent a promising approach for lineage forecasting and pandemic monitoring.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research used resources provided by the Darwin testbed at Los Alamos National Laboratory (LANL) which is funded by the Computational Systems and Software Environments subprogram of LANL's Advanced Simulation and Computing program (NNSA/DOE).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
